Danimer Scientific Announces $20 Million Asset-Based Revolving Credit Facility
2024年4月22日 - 9:30PM
ビジネスワイヤ(英語)
Danimer Scientific, Inc. (NYSE: DNMR) (the “Company” or “Danimer
Scientific”), a leading next generation bioplastics company focused
on the development and production of biodegradable materials,
announced today, that on April 19, 2024, it entered into an
asset-based revolving credit and security agreement with Mountain
Ridge Capital secured primarily by the Company’s accounts
receivable and inventory.
The credit and security agreement provides for borrowings under
a revolving commitment of $20 million with availability determined
by a borrowing base formula as provided in the agreement. The
agreement, among other things, also allows for increases in the
commitment up to an additional $5 million and matures on or about
April 19, 2027 (earlier maturity is subject to occurrence of
certain events). Revolving loans are expected to be used, among
other things, for general corporate purposes and working capital
needs as permitted by the credit and security agreement.
About Danimer Scientific
Danimer is a pioneer in creating more sustainable, more natural
ways to make plastic products. For more than a decade, its
renewable and sustainable biopolymers have helped create plastic
products that are biodegradable and compostable and return to
nature instead of polluting our lands and waters. Danimer’s
technology can be found in a vast array of plastic end products
that people use every day. Applications for its biopolymers include
additives, aqueous coatings, fibers, filaments, films and
injection-molded articles, among others. Danimer holds more than
480 granted patents and pending patent applications in more than 20
countries for a range of manufacturing processes and biopolymer
formulations. For more information, visit
https://danimerscientific.com.
Forward‐Looking Statements
Please note that in this press release we may use words such as
“appears,” “anticipates,” “believes,” “plans,” “expects,”
“intends,” “future,” and similar expressions which constitute
forward-looking statements within the meaning of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, without limitation, statements
regarding the Company’s expectations for our future and operational
performance. Forward-looking statements are made based on our
expectations and beliefs concerning future events impacting the
Company and therefore involve a number of risks and uncertainties.
We caution that forward-looking statements are not guarantees and
that actual results could differ materially from those expressed or
implied in the forward-looking statements. Potential risks and
uncertainties that could cause the actual results of operations or
financial condition of the Company to differ materially from those
expressed or implied by forward-looking statements in this release
include, but are not limited to, the overall level of consumer
demand on our products; general economic conditions and other
factors affecting consumer confidence, preferences, and behavior;
disruption and volatility in the global currency, capital, and
credit markets; the financial strength of the Company's customers;
the Company's ability to implement its business strategy,
including, but not limited to, its ability to expand its production
facilities and plants to meet customer demand for its products and
the timing thereof; risks relating to the uncertainty of the
projected financial information with respect to the Company; the
ability of the Company to execute and integrate acquisitions;
changes in governmental regulation, legislation or public opinion
relating to our products; the Company’s exposure to product
liability or product warranty claims and other loss contingencies;
disruptions and other impacts to the Company’s business, as a
result of the COVID-19 global pandemic and government actions and
restrictive measures implemented in response; stability of the
Company’s manufacturing facilities and suppliers, as well as
consumer demand for our products, in light of disease epidemics and
health-related concerns such as the COVID-19 global pandemic; the
impact on our business, operations and financial results from the
ongoing conflict in Ukraine; the impact that global climate change
trends may have on the Company and its suppliers and customers; the
Company's ability to protect patents, trademarks and other
intellectual property rights; any breaches of, or interruptions in,
our information systems; the ability of our information technology
systems or information security systems to operate effectively,
including as a result of security breaches, viruses, hackers,
malware, natural disasters, vendor business interruptions or other
causes; our ability to properly maintain, protect, repair or
upgrade our information technology systems or information security
systems, or problems with our transitioning to upgraded or
replacement systems; the impact of adverse publicity about the
Company and/or its brands, including without limitation, through
social media or in connection with brand damaging events and/or
public perception; fluctuations in the price, availability and
quality of raw materials and contracted products as well as foreign
currency fluctuations; our ability to utilize potential net
operating loss carryforwards; and changes in tax laws and
liabilities, tariffs, legal, regulatory, political and economic
risks. More information on potential factors that could affect the
Company's financial results is included from time to time in the
Company's public reports filed with the Securities and Exchange
Commission, including the Company's Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.
All forward-looking statements included in this press release are
based upon information available to the Company as of the date of
this press release and speak only as of the date hereof. We assume
no obligation to update any forward-looking statements to reflect
events or circumstances after the date of this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240422142700/en/
Investors Blake Chamblee Phone: 770-337-6570
ir@danimer.com Media Richard Ivey Phone: 229-254-7688
rivey@danimer.com
Danimer Scientific (NYSE:DNMR)
過去 株価チャート
から 5 2024 まで 6 2024
Danimer Scientific (NYSE:DNMR)
過去 株価チャート
から 6 2023 まで 6 2024